Difference between revisions of "Anal squamous cell carcinoma"
Jump to navigation
Jump to search
Line 50: | Line 50: | ||
DDx: | DDx: | ||
*[[Anal intraepithelial neoplasia]]. | *[[Anal intraepithelial neoplasia]]. | ||
*Poorly differentiated [[rectal adenocarcinoma]]. | |||
*[[Anal gland adenocarcinoma]]. | *[[Anal gland adenocarcinoma]]. | ||
===Images=== | ===Images=== |
Revision as of 18:12, 19 March 2015
Anal squamous cell carcinoma | |
---|---|
Diagnosis in short | |
Anal squamous cell carcinoma. H&E stain. | |
LM DDx | anal intraepithelial neoplasia |
Site | anus |
| |
Clinical history | +/-men who have sex with men, +/-immunodeficiency or immunosuppression |
Prevalence | most common anal cancer, overall uncommon |
Treatment | surgical excision |
Anal squamous cell carcinoma is the most common type of anal cancer.[1]
It is also known as anal squamous carcinoma and squamous cell carcinoma of the anus.
General
- Most common form of anal cancer.[1]
- Overall anal cancer uncommon.[1]
- Strong association with HPV.[2]
Risk factors:[3]
- Men who have sex with men.
- Immunosuppressed.
- HIV infection.
Microscopic
Features:
DDx:
- Anal intraepithelial neoplasia.
- Poorly differentiated rectal adenocarcinoma.
- Anal gland adenocarcinoma.
Images
IHC
Sign out
RECTUM, DISTAL, BIOPSY: - INVASIVE SQUAMOUS CELL CARCINOMA.
See also
- Anus.
References
- ↑ 1.0 1.1 1.2 Ghosn, M.; Kourie, HR.; Abdayem, P.; Antoun, J.; Nasr, D. (Feb 2015). "Anal cancer treatment: Current status and future perspectives.". World J Gastroenterol 21 (8): 2294-2302. doi:10.3748/wjg.v21.i8.2294. PMID 25741135.
- ↑ Cornall, AM.; Roberts, JM.; Garland, SM.; Hillman, RJ.; Grulich, AE.; Tabrizi, SN. (Nov 2013). "Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with "low-risk" HPV genotypes 6 and 11.". Int J Cancer 133 (9): 2253-8. doi:10.1002/ijc.28228. PMID 23616200.
- ↑ Kutlubay, Z.; Engin, B.; Zara, T.; Tüzün, Y.. "Anogenital malignancies and premalignancies: Facts and controversies.". Clin Dermatol 31 (4): 362-73. doi:10.1016/j.clindermatol.2013.01.003. PMID 23806153.
- ↑ 4.0 4.1 Gunia, S.; Koch, S.; May, M. (Feb 2013). "Is CDX2 immunostaining useful for delineating anorectal from penile/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis?". J Clin Pathol 66 (2): 109-12. doi:10.1136/jclinpath-2012-201138. PMID 23105122.